Development of Colorectal-Targeted Dietary Supplement Tablets Containing Natural Purple Rice Bran Oil as a Colorectal Chemopreventive
Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the r...
Saved in:
Published in: | Nutrients Vol. 10; no. 4; p. 444 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Switzerland
MDPI AG
04-04-2018
MDPI |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao' Gam Leum-Phua (KGLP), Khao' Gam Boung (KGB), Khao' Gam Thor (KGT), Khao' Gam Pah E-Kaw (KGPEK), and Khao' Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit
L100 and Eudragit
NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil
was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system. |
---|---|
AbstractList | Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao' Gam Leum-Phua (KGLP), Khao' Gam Boung (KGB), Khao' Gam Thor (KGT), Khao' Gam Pah E-Kaw (KGPEK), and Khao' Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit®L100 and Eudragit® NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil® was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system. Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao’ Gam Leum-Phua (KGLP), Khao’ Gam Boung (KGB), Khao’ Gam Thor (KGT), Khao’ Gam Pah E-Kaw (KGPEK), and Khao’ Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit®L100 and Eudragit® NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil® was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system. Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao' Gam Leum-Phua (KGLP), Khao' Gam Boung (KGB), Khao' Gam Thor (KGT), Khao' Gam Pah E-Kaw (KGPEK), and Khao' Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit L100 and Eudragit NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system. Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn’s disease and ulcerative colitis. It has been found that the inhibitory enzyme cyclooxygenase-2 (COX-2) in the colorectal region can potentially reduce the risk of colorectal cancer. The present study investigated rice bran oil from natural purple rice bran, which exhibits antioxidant and anti-inflammatory activity. This study aimed to evaluate the bioactive compound content of natural purple rice bran oil (NPRBO) derived from native Thai purple rice and the anti-inflammatory activity of NPRBO in colorectal cancer cells, and to develop a colorectal delivery platform in the form of film-coated tablets. NPRBO from the rice bran of five different Thai purple rice cultivars, namely Khao’ Gam Leum-Phua (KGLP), Khao’ Gam Boung (KGB), Khao’ Gam Thor (KGT), Khao’ Gam Pah E-Kaw (KGPEK), and Khao’ Niaw Dam (KND), were extracted using the supercritical carbon dioxide extraction technique. The amount of γ-oryzanol (ORY), tocotrienols, and tocopherols present in NPRBOs and the in vitro anti-inflammatory activity of NPRBO were investigated. The highest anti-inflammatory NPRBO was transformed into a dry and free-flowing powder by liquisolid techniques. Then, it was compressed into core tablets and coated with Eudragit ® L100 and Eudragit ® NE30D. The in vitro release study of the film-coated NPRBO tablets was performed in three-phase simulated gastrointestinal media. The cultivar KGLP was superior to the other samples in terms of the ORY, tocotrienol and tocopherol contents and anti-inflammatory activity. Aerosil ® was the most suitable absorbent for transforming NPRBO into a free-flowing powder and was used to prepare the NPRBO core tablets. The in vitro KGLP-NPRBO film-coated tablet release profile showed that no ORY was released at gastric pH while 85% of ORY was released at pH 7.4 after 6 h; this would be expected to occur in the colorectal area. Therefore, this study demonstrates the potential of KGLP-NPRBO to prevent colorectal cancer via a specific colorectal dietary supplement delivery system. |
Author | Saenjum, Chalermpong Sivamaruthi, Bhagavathi Sundaram Sirithunyalug, Jakkapan Tipduangta, Pratchaya Sirithunyalug, Busaban Charumanee, Suporn Chaiyasut, Chaiyavat |
AuthorAffiliation | 1 Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand; busaban.s@cmu.ac.th (B.S.); chalermpong.saenjum@gmail.com (C.S.); chsuporn@gmail.com (S.C.); sivasgene@gmail.com (B.S.S.); chaiyavat@gmail.com (C.C.); Jakkapan.S@cmu.ac.th (J.S.) 2 Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand 3 Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand |
AuthorAffiliation_xml | – name: 1 Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand; busaban.s@cmu.ac.th (B.S.); chalermpong.saenjum@gmail.com (C.S.); chsuporn@gmail.com (S.C.); sivasgene@gmail.com (B.S.S.); chaiyavat@gmail.com (C.C.); Jakkapan.S@cmu.ac.th (J.S.) – name: 2 Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand – name: 3 Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand |
Author_xml | – sequence: 1 givenname: Busaban surname: Sirithunyalug fullname: Sirithunyalug, Busaban email: busaban.s@cmu.ac.th, busaban.s@cmu.ac.th organization: Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand. busaban.s@cmu.ac.th – sequence: 2 givenname: Chalermpong surname: Saenjum fullname: Saenjum, Chalermpong email: chalermpong.saenjum@gmail.com, chalermpong.saenjum@gmail.com organization: Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand. chalermpong.saenjum@gmail.com – sequence: 3 givenname: Suporn surname: Charumanee fullname: Charumanee, Suporn email: chsuporn@gmail.com organization: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. chsuporn@gmail.com – sequence: 4 givenname: Bhagavathi Sundaram orcidid: 0000-0002-5499-8350 surname: Sivamaruthi fullname: Sivamaruthi, Bhagavathi Sundaram email: sivasgene@gmail.com, sivasgene@gmail.com organization: Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand. sivasgene@gmail.com – sequence: 5 givenname: Chaiyavat surname: Chaiyasut fullname: Chaiyasut, Chaiyavat email: chaiyavat@gmail.com, chaiyavat@gmail.com organization: Innovation Center for Holistic Health, Nutraceuticals and Cosmeceuticals, Faculty of Pharmacy, Chiang Mai University; Chiang Mai 50200, Thailand. chaiyavat@gmail.com – sequence: 6 givenname: Jakkapan surname: Sirithunyalug fullname: Sirithunyalug, Jakkapan email: Jakkapan.S@cmu.ac.th, Jakkapan.S@cmu.ac.th organization: Cluster of Excellence on Biodiversity based Economics and Society (B.BES-CMU), Chiang Mai University, Chiang Mai 50200, Thailand. Jakkapan.S@cmu.ac.th – sequence: 7 givenname: Pratchaya surname: Tipduangta fullname: Tipduangta, Pratchaya email: P.Tipduangta@gmail.com organization: Department of Pharmaceutical Sciences, Faculty of Pharmacy, Chiang Mai University, Chiang Mai 50200, Thailand. P.Tipduangta@gmail.com |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29617306$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkt9uFCEUhyemxtbaGx_AkHhjTFYZYGC4MdGtf5o01uh6Tc4yZ7ZsWJgyzCY-gO8t2611KzeHwJeP3yHnaXUUYsCqel7TN5xr-jZMNaWCCiEeVSeMKjaTUvCjg_1xdTaOa7pbiirJn1THTMtacSpPqt_nuEUfhw2GTGJP5tHHhDaDny0grTBjR84dZki_yI9pGDzekgtYesxjwUMGF1xYka-QpwSefJtSoch3Z5F8SBDIlfMERgIHbjK_xk0cUnk7ZLfFZ9XjHvyIZ3f1tPr56eNi_mV2efX5Yv7-cmYb3uYZEyAVb6jqWqZby6FpG0lFJ_u65roDrWzHhdKaQYusp6K1qq5LkVK1VlJ-Wl3svV2EtRmS25S-TARnbg9iWhlI2VmPhklbW4aAloKgetlS2Sip-qZbQmctFte7vWuYlhvsbOmktP9A-vAmuGuzilvTaCEZ00Xw6k6Q4s2EYzYbN1r0HgLGaTSMMlYz3bS73C__Q9dxSqF8VaEEVUq1VBTq9Z6yKY5jwv4-TE3NbljMv2Ep8IvD-Pfo39HgfwA5GLwf |
CitedBy_id | crossref_primary_10_3390_molecules26123565 crossref_primary_10_1080_23312009_2018_1529259 crossref_primary_10_1002_efd2_86 crossref_primary_10_1111_jfbc_13487 crossref_primary_10_3390_antiox9060493 crossref_primary_10_3390_nu15112503 crossref_primary_10_1002_ptr_8131 crossref_primary_10_3390_molecules26175234 crossref_primary_10_5937_arhfarm72_40329 crossref_primary_10_3390_antiox11020305 crossref_primary_10_1208_s12249_020_01765_2 crossref_primary_10_29169_1927_5951_2019_09_04_2 crossref_primary_10_1016_j_trac_2020_115942 crossref_primary_10_3390_antiox10071144 |
Cites_doi | 10.1016/S0140-6736(10)60353-4 10.3310/hta14320 10.1016/j.supflu.2010.08.004 10.1038/35094017 10.1016/j.biopha.2009.09.018 10.1111/apt.13857 10.1016/S0378-8741(02)00205-2 10.1016/S1461-5347(99)00151-0 10.1038/bjp.2008.268 10.1038/sj.bjc.6603539 10.1093/carcin/bgp205 10.1016/S0169-409X(02)00071-6 10.1073/pnas.90.5.1771 10.1021/jf981175j 10.1021/jf034466n 10.2131/jts.16.191 10.1111/j.2042-7158.1997.tb06761.x 10.1590/1678-457X.6730 10.1089/jmf.2009.1118 10.1016/j.foodchem.2008.04.031 10.1016/0278-6915(92)90135-8 10.1007/s10561-006-9028-6 10.1002/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO;2-9 10.1021/jf0490293 10.1016/0003-2697(76)90527-3 10.1021/jf102224b 10.1016/j.bbrc.2007.04.178 10.1002/mnfr.200700418 |
ContentType | Journal Article |
Copyright | Copyright MDPI AG 2018 2018 by the authors. 2018 |
Copyright_xml | – notice: Copyright MDPI AG 2018 – notice: 2018 by the authors. 2018 |
DBID | NPM AAYXX CITATION 3V. 7TS 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PIMPY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.3390/nu10040444 |
DatabaseName | PubMed CrossRef ProQuest Central (Corporate) Physical Education Index Health & Medical Complete (ProQuest Database) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Publicly Available Content Database (Proquest) (PQ_SDU_P3) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals |
DatabaseTitle | PubMed CrossRef Publicly Available Content Database ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) Physical Education Index ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest Medical Library ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest One Academic ProQuest Medical Library (Alumni) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: Directory of Open Access Journals url: http://www.doaj.org/ sourceTypes: Open Website |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 2072-6643 |
ExternalDocumentID | oai_doaj_org_article_26c1c2eaec0a409b8065767f5dbadcce 10_3390_nu10040444 29617306 |
Genre | Journal Article |
GroupedDBID | --- 3V. 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ A8Z AADQD AAFWJ AAHBH AAWTL ABUWG ACIWK ACPRK ADRAZ AENEX AFKRA AFRAH AFZYC ALIPV ALMA_UNASSIGNED_HOLDINGS APEBS ATCPS BBNVY BENPR BHPHI BPHCQ BVXVI CCPQU DIK E3Z EBD ECGQY EIHBH ESTFP EYRJQ F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IPNFZ KQ8 LK8 M0K M1P M48 M7P MODMG M~E NPM OK1 P2P P6G PGMZT PIMPY PQQKQ PROAC PSQYO RIG RNS RPM TR2 UKHRP AAYXX CITATION 7TS 7XB 8FK AZQEC DWQXO K9. PQEST PQUKI PRINS 7X8 5PM AFPKN |
ID | FETCH-LOGICAL-c538t-24a673507d8298c3a585604d6f1139da97cd347992a8e2f048c7110486678c603 |
IEDL.DBID | RPM |
ISSN | 2072-6643 |
IngestDate | Tue Oct 22 15:15:54 EDT 2024 Tue Sep 17 21:06:26 EDT 2024 Fri Oct 25 02:07:59 EDT 2024 Thu Oct 10 22:21:38 EDT 2024 Thu Nov 21 23:02:57 EST 2024 Wed Oct 16 00:59:04 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | delivery system for dietary supplement gastrointestinal inflammatory diseases γ-oryzanol purple rice bran oil anti-inflammatory activity |
Language | English |
License | Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c538t-24a673507d8298c3a585604d6f1139da97cd347992a8e2f048c7110486678c603 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-5499-8350 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5946229/ |
PMID | 29617306 |
PQID | 2040777804 |
PQPubID | 2032353 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_26c1c2eaec0a409b8065767f5dbadcce pubmedcentral_primary_oai_pubmedcentral_nih_gov_5946229 proquest_miscellaneous_2022129580 proquest_journals_2040777804 crossref_primary_10_3390_nu10040444 pubmed_primary_29617306 |
PublicationCentury | 2000 |
PublicationDate | 2018-04-04 |
PublicationDateYYYYMMDD | 2018-04-04 |
PublicationDate_xml | – month: 04 year: 2018 text: 2018-04-04 day: 04 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland – name: Basel |
PublicationTitle | Nutrients |
PublicationTitleAlternate | Nutrients |
PublicationYear | 2018 |
Publisher | MDPI AG MDPI |
Publisher_xml | – name: MDPI AG – name: MDPI |
References | 17499610 - Biochem Biophys Res Commun. 2007 Jun 29;358(2):615-9 18587421 - Br J Pharmacol. 2008 Sep;155(2):198-209 11097223 - Cancer Epidemiol Biomarkers Prev. 2000 Nov;9(11):1163-70 17094019 - Cell Tissue Bank. 2007;8(3):179-86 20594533 - Health Technol Assess. 2010 Jun;14 (32):1-206 20731354 - J Agric Food Chem. 2010 Sep 22;58(18):10007-15 27859394 - Aliment Pharmacol Ther. 2017 Jan;45(2):193-204 17211473 - Br J Cancer. 2007 Jan 29;96(2):248-54 12413723 - J Ethnopharmacol. 2002 Nov;83(1-2):153-9 12926869 - J Agric Food Chem. 2003 Aug 27;51(18):5271-7 1798065 - J Toxicol Sci. 1991 Nov;16(4):191-202 10797271 - Int J Cancer. 2000 May 15;86(4):553-60 942051 - Anal Biochem. 1976 May 7;72:248-54 20041774 - J Med Food. 2009 Dec;12(6):1213-20 8446589 - Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1771-5 11900248 - Nat Rev Cancer. 2001 Oct;1(1):11-21 9120760 - J Pharm Pharmacol. 1997 Jan;49(1):105-7 15686439 - J Agric Food Chem. 2005 Feb 9;53(3):816-22 19748925 - Carcinogenesis. 2010 Apr;31(4):533-42 15816542 - Anticancer Res. 2005 Jan-Feb;25(1A):225-33 12363433 - Adv Drug Deliv Rev. 2002 Oct 4;54(6):825-50 10552553 - J Agric Food Chem. 1999 Jul;47(7):2724-8 19954924 - Biomed Pharmacother. 2010 May;64(5):327-32 18481320 - Mol Nutr Food Res. 2008 Aug;52(8):921-9 10322382 - Pharm Sci Technolo Today. 1999 May;2(5):197-204 1544605 - Food Chem Toxicol. 1992 Jan;30(1):41-8 20304247 - Lancet. 2010 Mar 20;375(9719):1030-47 ref35 ref12 ref15 ref14 ref31 ref30 ref11 ref33 ref2 Rubinstein (ref34) 2006 ref1 ref17 Malekian (ref13) 2000 ref16 ref19 ref18 (ref32) 2016; Volume 1 ref24 ref23 ref26 ref25 ref20 ref22 ref21 ref27 Hudson (ref5) 2000; 9 ref29 ref8 ref9 ref4 ref3 Srisala (ref7) 2009; 24 ref6 Buecher (ref28) 2005; 25 Saenjum (ref10) 2012; 6 |
References_xml | – ident: ref1 doi: 10.1016/S0140-6736(10)60353-4 – volume: Volume 1 start-page: 1749 year: 2016 ident: ref32 article-title: [1216] TABLET FRIABILITY – volume: 25 start-page: 225 year: 2005 ident: ref28 article-title: Growth inhibitory effect of celecoxib and rofecoxib on human colorectal carcinoma cell lines publication-title: Anticancer Res. contributor: fullname: Buecher – ident: ref3 doi: 10.3310/hta14320 – ident: ref14 doi: 10.1016/j.supflu.2010.08.004 – ident: ref30 doi: 10.1038/35094017 – ident: ref31 doi: 10.1016/j.biopha.2009.09.018 – start-page: 3 year: 2006 ident: ref34 article-title: Gastrointestinal anatomy, physiology and permeation pathways contributor: fullname: Rubinstein – ident: ref2 doi: 10.1111/apt.13857 – ident: ref17 doi: 10.1016/S0378-8741(02)00205-2 – ident: ref33 doi: 10.1016/S1461-5347(99)00151-0 – ident: ref23 doi: 10.1038/bjp.2008.268 – ident: ref9 doi: 10.1038/sj.bjc.6603539 – ident: ref26 doi: 10.1093/carcin/bgp205 – ident: ref35 doi: 10.1016/S0169-409X(02)00071-6 – ident: ref27 doi: 10.1073/pnas.90.5.1771 – ident: ref15 doi: 10.1021/jf981175j – ident: ref18 doi: 10.1021/jf034466n – ident: ref11 doi: 10.2131/jts.16.191 – ident: ref20 doi: 10.1111/j.2042-7158.1997.tb06761.x – ident: ref16 doi: 10.1590/1678-457X.6730 – ident: ref19 doi: 10.1089/jmf.2009.1118 – ident: ref4 doi: 10.1016/j.foodchem.2008.04.031 – volume: 24 start-page: 81 year: 2009 ident: ref7 article-title: Effects of bran extracts from thai molecular breeding rices on growth and apoptosis in human promyelocytic leukemia cells publication-title: Thai J. Toxicol. contributor: fullname: Srisala – ident: ref12 doi: 10.1016/0278-6915(92)90135-8 – ident: ref22 doi: 10.1007/s10561-006-9028-6 – ident: ref29 doi: 10.1002/(SICI)1097-0215(20000515)86:4<553::AID-IJC18>3.0.CO;2-9 – ident: ref6 doi: 10.1021/jf0490293 – ident: ref21 doi: 10.1016/0003-2697(76)90527-3 – volume: 9 start-page: 1163 year: 2000 ident: ref5 article-title: Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells publication-title: Cancer Epidemiol. Biomark. Prev. contributor: fullname: Hudson – ident: ref25 doi: 10.1021/jf102224b – ident: ref8 doi: 10.1016/j.bbrc.2007.04.178 – start-page: 1 year: 2000 ident: ref13 contributor: fullname: Malekian – volume: 6 start-page: 1070 year: 2012 ident: ref10 article-title: Antioxidant and anti-inflammatory activities of gamma-oryzanol rich extracts from thai purple rice bran publication-title: J. Med. Plants Res. contributor: fullname: Saenjum – ident: ref24 doi: 10.1002/mnfr.200700418 |
SSID | ssj0000070763 |
Score | 2.2946372 |
Snippet | Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn's disease and... Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn’s disease and... Colorectal cancer occurs due to various factors. The important risks are dietary lifestyle and inflammatory bowel diseases, such as Crohn&rsquo;s disease... |
SourceID | doaj pubmedcentral proquest crossref pubmed |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | 444 |
SubjectTerms | anti-inflammatory activity Anti-inflammatory agents Antioxidants Bioactive compounds Carbon dioxide Coating Coatings Colorectal cancer Colorectal carcinoma Cultivars Cyclooxygenase-2 delivery system for dietary supplement Dietary fiber Dietary supplements gastrointestinal inflammatory diseases Health risks Inflammatory bowel diseases Intestine Oils & fats Oryza Powder purple rice bran oil Rice bran Rice bran oil Risk factors Tablets Tocopherol Tocopherols Ulcerative colitis Vegetable oils γ-oryzanol |
SummonAdditionalLinks | – databaseName: Directory of Open Access Journals dbid: DOA link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BT1wQpQ8CBQ0q6i1q4jh2fOxTPRUEi9Rb5PghVlqyqLuL1B_Q_82Ms112UaVeuMZW4nhmPPPZ428APnUEtyI5rtzWPubSSpMb733eUEOQ0QSfyHSuvunrm-b8gmlyVqW-OCdsoAceJu5YKFc6EWxwhSUs0vFBoFY61r6z3rmQVt9CrYGpIfDVBNCrgY-0Ilx_3C-YG43Z0TY8UCLqfyy6_DdJcs3rXL6Cl8twEU-GYW7Ds9C_hp2TnqDyzzs8wpTAmXbGd-B-LQEIpxHP6DmvZ3aSj1K-d_B4Pg5ze3uHqZhn2hnEEV-ems-QeaqGchF4bRMbB34hKUwCfqXFBE_JqeHn8QTtDO3au5EpB7iUSkqc_B124fvlxejsKl9WWcgdLXbzXEirdEVhoW-EaVxlCUCoQnoVS4oOvTXaeb5uaoRtgohk8U5TzCAbRX7OqaLag61-2oc3gGUk9FF2JOsQuZB1p7zQZZSuLJ2Xtcjg8GHm218DmUZLIITl0_6VTwanLJRVDybATg9ILdqlWrRPqUUGBw8ibZdWOWsFfUBrplzK4OOqmeyJD0lsH6YL7iPIm5u6KTLYHzRgNRJhKN4jjJWB3tCNjaFutvTjH4mzuzZSCWHe_o9_ewcvKGxrUv6QPICt-e0ivIfnM7_4kKzgD0NxEJM priority: 102 providerName: Directory of Open Access Journals |
Title | Development of Colorectal-Targeted Dietary Supplement Tablets Containing Natural Purple Rice Bran Oil as a Colorectal Chemopreventive |
URI | https://www.ncbi.nlm.nih.gov/pubmed/29617306 https://www.proquest.com/docview/2040777804 https://search.proquest.com/docview/2022129580 https://pubmed.ncbi.nlm.nih.gov/PMC5946229 https://doaj.org/article/26c1c2eaec0a409b8065767f5dbadcce |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6xPXFBQHkEysoIxC3djePE8bHdtipClAoWiVvk-AEr7WarfSD1B_R_d8ZJlizixDXOw8qMPfPZn78BeF8h3PIYuGKdWR8LLVSsrLVxgQ1OeOVsENO5_CavfhRn5ySTk3VnYQJp31Sz43q-OK5nvwK38mZhRh1PbHT9eZIpkXOuRgMYYG7Yg-hNzisRm6eNFGmKkH5Ub0kWjYTRSPpXYcxOqcBRLw4Fuf5_5Zh_UyV7sefiMTxqk0Z20nTuCTxw9VM4PKkRMC9u2QcWaJxhffwQ7no0ILb0bILXaVbT83gaWN_OsrOZ2-jVLQslPcP6IJvSEarNmpFaVVM0gl3poMnBrtEWc8e-4pTCTjG0sS-zOdNrpnvvZiQ8QAVVAn3yt3sG3y_Op5PLuK21EBuc8jYxFzqXKSaHtuCqMKlGGJGPhc19gjmi1UoaS4dOFdeF4x7HvZGYOYgix2hn8nH6HA7qZe1eAks8YpCkQos7T-Wsq9xymXhhksRYkfEI3nV_vrxpJDVKhCJkqvKPqSI4JaPs7iAZ7HBhufpZts5Q8twkhjvtzFgjUK1ol1jm0me20tYYF8FRZ9KyHZvrkuMHpCThpQje7ppxVNFWia7dckv3cIzpKivGEbxoPGDXk86DIpB7vrHX1f0WdOSg3N067qv_fvI1PMSMrQjUIXEEB5vV1r2Bwdpuh4gHPn4ahjWFYRgR95U-EYc |
link.rule.ids | 230,315,729,782,786,866,887,2106,27933,27934,53800,53802 |
linkProvider | National Library of Medicine |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Nb9QwEB3RcoALUAolUIoRiFu6iePE8bHdtlpEu1SwSNwixx_tSrvZaj-Q-gP434ydZJutOPVqO4mVGXvmJc9vAD6XCLcsBq5QptqGTDIRCq11mGOHYVYY7cV0Bj_58Hd-cupkctL2LIwn7atyfFhNpofV-NpzK2-mqtfyxHqXF_1UsIxS0duCx7heo6gD0uuslyM6T2ox0gRBfa9aOWE0J43mxH8FRu3ElTjqRCIv2P-_LPM-WbITfc6eP3DeL-BZk26So7p7Bx6Z6iXsHlUItae35AvxBFD_ZX0X_nYIRGRmSR_b3X4oJ-HI88WNJidjs5TzW-KLgfovi2TkDl8tF8TpXNXlJshQejUPcolWnBjyAzcjcoxBkXwfT4hcENm5N3GSBa4Uiyde_jGv4NfZ6ag_CJsqDaHCl78MKZMZTzCt1DkVuUokApAsYjqzMWaXWgqutDuuKqjMDbW4YyiOOQfLM4yTKouS17BdzSrzBkhsEb3EJfqKsa4QdplpymPLVBwrzVIawKfWYsVNLcZRIIhxJi7uTBzAsTPmeoQT0PYNs_lV0ZijoJmKFTXSqEgixC3d_2WecZvqUmqlTAD7rSsUzapeFBQfwLmTbArg47ob16P7ySIrM1u5MRSzAZHmUQB7teesZ9J6XgB8w6c2prrZg67kNb8b13n74Cs_wJPB6OK8OP86_PYOnmLel3sCEtuH7eV8Zd7D1kKvDvxK-gcvfCUm |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB6xi4S48FpYAgsYgbhlkzhOHB93260WAaWCInGLHD-gUptWfay0P2D_N2MnLSniBNfYSSzN2DOf_fkbgLcVwi2LgSuUmbYhk0yEQmsdFthgmBVGezGdy698-L3oXziZnF2pL0_aV9XktJ7OTuvJT8-tXMxUtOWJRaNPvUywnFIRLbSNDuA2ztmYdoB6k_lyROhpI0iaIrCP6o0TR3PyaE4AWGDkTl2Zo0408qL9f8s0_yRMdiLQ4P5_jP0B3GvTTnLWdHkIt0z9CI7OaoTcs2vyjngiqN9hP4KbDpGIzC3p4XO3LsppOPa8caNJf2LWcnlNfFFQv8NIxu4S1npFnN5VU3aCDKVX9SAjtObUkC-4KJFzDI7k82RK5IrIzreJky5wJVk8AfPKPIZvg4tx7zJsqzWECg2wDimTOU8xvdQFFYVKJQKRPGY6twlmmVoKrrS7tiqoLAy1uHIojrkHK3KMlyqP0ydwWM9r8xRIYhHFJBX6jLGuIHaVa8oTy1SSKM0yGsCbrdXKRSPKUSKYcWYuf5s5gHNn0F0PJ6TtH8yXP8rWJCXNVaKokUbFEqFu5c6Zec5tpiuplTIBnGzdoWxn96qk-APOnXRTAK93zTgv3WGLrM184_pQzApEVsQBHDfesxvJ1vsC4Ht-tTfU_RZ0J6_93brPs39-8xXcGfUH5cf3ww_P4S6mf4XnIbETOFwvN-YFHKz05qWfTL8ATywnpg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Development+of+Colorectal-Targeted+Dietary+Supplement+Tablets+Containing+Natural+Purple+Rice+Bran+Oil+as+a+Colorectal+Chemopreventive&rft.jtitle=Nutrients&rft.au=Sirithunyalug%2C+Busaban&rft.au=Saenjum%2C+Chalermpong&rft.au=Charumanee%2C+Suporn&rft.au=Sivamaruthi%2C+Bhagavathi+Sundaram&rft.date=2018-04-04&rft.eissn=2072-6643&rft.volume=10&rft.issue=4&rft_id=info:doi/10.3390%2Fnu10040444&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2072-6643&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2072-6643&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2072-6643&client=summon |